Microfluidic manufacturing of surface-functionalized graphene oxide nanoflakes for gene delivery

Nanoscale ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 2733-2741 ◽  
Author(s):  
Riccardo Di Santo ◽  
Luca Digiacomo ◽  
Sara Palchetti ◽  
Valentina Palmieri ◽  
Giordano Perini ◽  
...  

Microfluidic assembly of graphene oxide nanoflakes and cationic lipids produces surface functionalized hybrid nanoparticles with superior transfection efficiency and no cytotoxicity.

RSC Advances ◽  
2016 ◽  
Vol 6 (27) ◽  
pp. 22461-22468 ◽  
Author(s):  
Chunyang Wang ◽  
Xiaoqin Wang ◽  
Tong Lu ◽  
Fangshi Liu ◽  
Baofeng Guo ◽  
...  

A novel and efficient graphene-based gene delivery vector was prepared, the effect of changing the PEI content on the size, stability and transfection efficiency were investigated.


2015 ◽  
Vol 19 (18) ◽  
pp. 1828-1837 ◽  
Author(s):  
George V. Theodosopoulos ◽  
Panayiotis Bilalis ◽  
Georgios Sakellariou

2015 ◽  
Vol 17 (9) ◽  
pp. 6328-6339 ◽  
Author(s):  
Rana Imani ◽  
Shahriar Hojjati Emami ◽  
Shahab Faghihi

The success of gene therapy is largely dependent on the development of a gene carrier.


Small ◽  
2011 ◽  
Vol 7 (11) ◽  
pp. 1569-1578 ◽  
Author(s):  
Hongqian Bao ◽  
Yongzheng Pan ◽  
Yuan Ping ◽  
Nanda Gopal Sahoo ◽  
Tongfei Wu ◽  
...  

2011 ◽  
Vol 21 (21) ◽  
pp. 7736 ◽  
Author(s):  
Biao Chen ◽  
Min Liu ◽  
Liming Zhang ◽  
Jie Huang ◽  
Jianlin Yao ◽  
...  

2020 ◽  
Vol 27 (8) ◽  
pp. 698-710
Author(s):  
Roya Cheraghi ◽  
Mahboobeh Nazari ◽  
Mohsen Alipour ◽  
Saman Hosseinkhani

Gene-based therapy largely relies on the vector type that allows a selective and efficient transfection into the target cells with maximum efficacy and minimal toxicity. Although, genes delivered utilizing modified viruses transfect efficiently and precisely, these vectors can cause severe immunological responses and are potentially carcinogenic. A promising method of overcoming this limitation is the use of non-viral vectors, including cationic lipids, polymers, dendrimers, and peptides, which offer potential routes for compacting DNA for targeted delivery. Although non-viral vectors exhibit reduced transfection efficiency compared to their viral counterpart, their superior biocompatibility, non-immunogenicity and potential for large-scale production make them increasingly attractive for modern therapy. There has been a great deal of interest in the development of biomimetic chimeric peptides. Biomimetic chimeric peptides contain different motifs for gene translocation into the nucleus of the desired cells. They have motifs for gene targeting into the desired cell, condense DNA into nanosize particles, translocate the gene into the nucleus and enhance the release of the particle into the cytoplasm. These carriers were developed in recent years. This review highlights the stepwise development of the biomimetic chimeric peptides currently being used in gene delivery.


Sign in / Sign up

Export Citation Format

Share Document